Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us Biotech Cell & Gene Therapy Clinical Data Venture Capital Deals Research Medtech Devices Diagnostics AI and Machine Learning CRO Special Reports Trending Topics Diabetes Fierce 50 Special Report Awards Gala Resources Fierce Events Industry Events Webinars Podcasts Whitepapers Survey Events Subscribe Subscribe Biotech Cell & Gene Therapy Clinical Data Venture Capital Deals Research Medtech Devices Diagnostics AI and Machine Learning CRO Special Reports Trending Topics Diabetes Fierce 50 Special Report Awards Gala Resources Fierce Events Industry Events Webinars Podcasts Whitepapers Survey Events Subscribe Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us Stories Sponsored Anticipating the disruption of regenerative medicine Fronts Teaser Travis McCready, Head of Life Sciences for Americas at JLL, highlights regenerative medicine and tissue engineering as spaces to watch in biotech. Sponsored by JLL Sponsored Science is science: Market corrections create opportunities for life sciences companies. Fronts Teaser The real estate market for life sciences may be choppy, but the correction is creating opportunities for small and large companies. Sponsored by JLL
Sponsored Anticipating the disruption of regenerative medicine Fronts Teaser Travis McCready, Head of Life Sciences for Americas at JLL, highlights regenerative medicine and tissue engineering as spaces to watch in biotech. Sponsored by JLL
Sponsored Science is science: Market corrections create opportunities for life sciences companies. Fronts Teaser The real estate market for life sciences may be choppy, but the correction is creating opportunities for small and large companies. Sponsored by JLL